Keyphrases
Abbott RealTime
100%
Amplicor
20%
Antiviral Treatment
100%
Chronic Hepatitis C
100%
Cobas
20%
End of Treatment
80%
Hepatitis C
20%
Hepatitis C Virus Genotypes
20%
Hepatitis C Virus RNA
100%
MRNA Level
60%
No Significant Difference
20%
Nonsustained
40%
PCR Assay
100%
Pegylated Interferon alfa-2a
20%
Quantitative PCR
100%
Relapse Rate
20%
Ribavirin Treatment
20%
Serum Hepatitis
20%
Serum Samples
20%
Sustained Virological Response
100%
Viremia
20%
Virological Response
100%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha2b Interferon Plus Ribavirin
20%
Antivirus Agent
100%
Chronic Hepatitis C
100%
Hepatitis B
20%
Hepatitis C Virus
100%
Hepatitis C Virus Subtype 1b
20%
Peginterferon Alpha2b
20%
Recurrence Risk
20%
Viremia
20%
Virus RNA
100%
Medicine and Dentistry
Alpha2b Interferon Plus Ribavirin
20%
Antiviral Therapy
100%
Chronic Hepatitis C
100%
Hepatitis B
20%
Hepatitis C Virus
100%
Hepatitis C Virus Subtype 1b
20%
Peginterferon Alpha2b
20%
Recurrence Risk
20%
Viremia
20%
Virus RNA
100%
Immunology and Microbiology
Alpha2b Interferon Plus Ribavirin
20%
Hepatitis B
20%
Hepatitis C
100%
Hepatitis C Virus
100%
Hepatitis C Virus Subtype 1b
20%
Peginterferon Alfa-2b
20%
RNA Virus
100%
Viremia
20%